Armune BioScience Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Armune BioScience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012939
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests for prostate, lung and breast cancers, which helps the physicians to differentiate between indolent and aggressive prostate cancer. Armune has developed a phage protein microarray method to characterize autoantibody in cancer. The company is developing a prostate cancer diagnostic blood test having high sensitivity and specificity. Its research laboratory is located in Ann Arbor. Armune is headquartered in Kalamazoo, Michigan, the US.

Armune BioScience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Armune BioScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Armune BioScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Armune BioScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Armune BioScience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Armune BioScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Armune BioScience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Armune BioScience Raises USD0.5 Million in Venture Financing 10
Armune BioScience Raises USD5 Million in Series A Venture Financing 11
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 12
Armune BioScience to Raise USD25 Million in Series B Financing 13
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 14
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 15
Armune BioScience Raises USD3.5 Million in Venture Financing 16
Armune BioScience Raises US$1.4 Million In Venture Financing 17
Partnerships 18
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 18
Armune BioScience Inc – Key Competitors 19
Armune BioScience Inc – Key Employees 20
Armune BioScience Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Product News 22
02/23/2016: Aeterna Zentaris Commences Promotional Activities for APIFINY Prostate Cancer Blood Test 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Armune BioScience Inc, Medical Equipment, Key Facts 2
Armune BioScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Armune BioScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Armune BioScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Armune BioScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Armune BioScience Inc, Deals By Market, 2011 to YTD 2017 8
Armune BioScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Armune BioScience Raises USD0.5 Million in Venture Financing 10
Armune BioScience Raises USD5 Million in Series A Venture Financing 11
Armune BioScience Raises USD4 Million in Second and Final Tranche of Series A Financing 12
Armune BioScience to Raise USD25 Million in Series B Financing 13
Armune BioScience Raises Additional USD5.6 Million in Venture Financing 14
Armune Biosciences Raises USD2.5 Million in Series A Venture Financing 15
Armune BioScience Raises USD3.5 Million in Venture Financing 16
Armune BioScience Raises US$1.4 Million In Venture Financing 17
Aeterna Zentaris Expands its Co-Marketing Agreement with Armune BioScience 18
Armune BioScience Inc, Key Competitors 19
Armune BioScience Inc, Key Employees 20

★海外企業調査レポート[Armune BioScience Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kadmon Holdings Inc (KDMN):企業の財務・戦略的SWOT分析
    Kadmon Holdings Inc (KDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Experian plc:企業の戦略・SWOT・財務情報
    Experian plc - Strategy, SWOT and Corporate Finance Report Summary Experian plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spanish National Cancer Research Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that conducts cancer research programs. The center integrates basic and translational cancer research. It conducts various scientific programs, which include molecular oncology program, structural biology and biocomp …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GHD Pty Ltd:企業の戦略・SWOT・財務分析
    GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Yanlord Land Group Ltd:戦略・SWOT・企業財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chiyoda Corporation (6366)-石油・ガス分野:企業M&A・提携分析
    Summary Chiyoda Corporation (Chiyoda) is an engineering services provider that offers various services along with its subsidiaries. Its offerings include project management, program management, feasibility studies, front end engineering design works, engineering, procurement, construction, commissio …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Jacquet Metal Service SA:企業の戦略・SWOT・財務情報
    Jacquet Metal Service SA - Strategy, SWOT and Corporate Finance Report Summary Jacquet Metal Service SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Manulife Financial Corporation:戦略・SWOT・企業財務分析
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析
    Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Colfax Corporation (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Societe Tunisienne de l’Electricite et du Gaz:企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Altor BioScience Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Altor BioScience Corp (Altor BioScience) is a biopharmaceutical company that develops immunotherapies for the treatment of cancer and viral infections. The company’s pipeline products include ALT-801, ALT-836, and ALT-803. Its technologies are soluble t-cell antigen receptor, inhibitor of MH …
  • University College London Hospitals NHS Foundation Trust:企業の戦略的SWOT分析
    University College London Hospitals NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Corbion NV (CRBN):企業の財務・戦略的SWOT分析
    Corbion NV (CRBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆